M. Tomirotti et al., RECOVERY OF RESPONSE TO ADRIAMYCIN AND CYCLOPHOSPHAMIDE BY LONIDAMINEIN PREVIOUSLY TREATED METASTATIC BREAST-CANCER PATIENTS, International journal of oncology, 3(2), 1993, pp. 213-217
Thirty-one patients with metastatic breast cancer not responding or pr
ogressing after initial response to adriamycin + cyclophosphamide (AC)
treatment entered a phase 11 study with oral lonidamine in associatio
n to AC. Objective clinical responses were observed in 10 patients (32
%) and consisted of 1 complete + 9 partial remissions. Disease stabili
ty and progression were observed in 8 and 13 cases, respectively. Thes
e results were obtained with a marginal toxicity in addition to that a
lready reported for AC therapy, the main additional side effect being
myalgia, which was easily manageable in most cases.